Cormedix Stock Price on December 30, 2024
| CRMD Stock | USD 7.93 0.25 3.06% |
Below is the normalized historical share price chart for CorMedix extending back to May 13, 2010. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of CorMedix stands at 7.93, as last reported on the 6th of January, with the highest price reaching 8.34 and the lowest price hitting 7.91 during the day.
If you're considering investing in CorMedix Stock, it is important to understand the factors that can impact its price. CorMedix secures Sharpe Ratio (or Efficiency) of -0.0461, which signifies that the company had a -0.0461% return per unit of risk over the last 3 months. CorMedix exposes twenty-eight different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm CorMedix's Downside Deviation of 5.18, mean deviation of 3.16, and Risk Adjusted Performance of 0.0302 to double-check the risk estimate we provide.
At present, CorMedix's Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 77.5 M, whereas Common Stock Total Equity is forecasted to decline to about 36.2 K. . At present, CorMedix's Price To Book Ratio is projected to slightly grow based on the last few years of reporting. The current year's Price Fair Value is expected to grow to 2.58, whereas Price Earnings Ratio is forecasted to decline to (4.99). CorMedix Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 25th of March 2010 | 200 Day MA 6.751 | 50 Day MA 9.9618 | Beta 1.582 |
CorMedix |
Sharpe Ratio = -0.0461
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CRMD |
Estimated Market Risk
| 4.57 actual daily | 40 60% of assets are more volatile |
Expected Return
| -0.21 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average CorMedix is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CorMedix by adding CorMedix to a well-diversified portfolio.
Price Book 8.4538 | Enterprise Value Ebitda (3.50) | Price Sales 40.4771 | Shares Float 60.1 M | Wall Street Target Price 16.25 |
Related Headline
Precigen Headline on 30th of December 2024
Precigen Soars Biologics License Application Submission For ... by finance.yahoo.com
Precigen, Inc. shares are trading higher on Monday after the company completed the rolling submission for a biologics license application to the FDA for PRGN-2012 to treat adult patients with recurrent respiratory papillomatosis. PRGN-2012 is an investigational AdenoVerse gene therapy targeting HPV 6 and HPV 11 infections. It has received Breakthrough Therapy and Orphan Drug Designations from the FDA, and Orphan Drug Designation from the European Commission.
CorMedix Valuation on December 30, 2024
It is possible to determine the worth of CorMedix on a given historical date. On December 30, 2024 CorMedix was worth 8.13 at the beginning of the trading date compared to the closed value of 8.1. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of CorMedix stock. Still, in general, we apply an absolute valuation method to find CorMedix's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of CorMedix where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against CorMedix's related companies.
| Open | High | Low | Close | Volume | |
| 8.41 | 8.49 | 8.06 | 8.21 | 474,722 | |
12/30/2024 | 8.13 | 8.15 | 7.92 | 8.10 | 712,917 |
| 8.19 | 8.23 | 7.79 | 8.10 | 1,152,047 |
| Backtest CorMedix | | | CorMedix History | | | CorMedix Valuation | Previous | Next |
CorMedix Trading Date Momentum on December 30, 2024
| On December 31 2024 CorMedix was traded for 8.10 at the closing time. The top price for the day was 8.23 and the lowest listed price was 7.79 . The trading volume for the day was 1.2 M. The trading history from December 31, 2024 did not affect price variability. The overall trading delta against the current closing price is 1.85% . |
CorMedix Fundamentals Correlations and Trends
By evaluating CorMedix's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among CorMedix's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. CorMedix financial account trend analysis is a perfect complement when working with valuation or volatility modules.About CorMedix Stock history
CorMedix investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for CorMedix is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in CorMedix will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing CorMedix stock prices may prove useful in developing a viable investing in CorMedix
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 58.5 M | 61.5 M | |
| Net Loss | -26.7 M | -28.1 M |
CorMedix Quarterly Net Working Capital |
|
CorMedix Stock Technical Analysis
CorMedix technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
CorMedix Period Price Range
Low | January 6, 2025
| High |
0.00 | 0.00 |
CorMedix cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
CorMedix January 6, 2025 Market Strength
Market strength indicators help investors to evaluate how CorMedix stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading CorMedix shares will generate the highest return on investment. By undertsting and applying CorMedix stock market strength indicators, traders can identify CorMedix entry and exit signals to maximize returns
CorMedix Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for CorMedix's price direction in advance. Along with the technical and fundamental analysis of CorMedix Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of CorMedix to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0302 | |||
| Jensen Alpha | 0.1041 | |||
| Total Risk Alpha | 0.0445 | |||
| Sortino Ratio | 0.0197 | |||
| Treynor Ratio | 0.1405 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for CorMedix Stock analysis
When running CorMedix's price analysis, check to measure CorMedix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CorMedix is operating at the current time. Most of CorMedix's value examination focuses on studying past and present price action to predict the probability of CorMedix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CorMedix's price. Additionally, you may evaluate how the addition of CorMedix to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |